Transgene Announces Upcoming Investor Meetings

On August 29, 2019 Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies against cancers reported that Management will participate in the upcoming investor events set out below:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H. C. Wainwright Annual Global Investment Conference: September 9 & 10, 2019 – New York, USA
Portzamparc Biotech Conference: September 10, 2019 – Paris, France
Large & Midcap Event: October 14 & 15, 2019 – Paris, France
Bryan Garnier Annual Healthcare Conference: November 12, 2019 – Paris, France
Actionaria: November 21 & 22, 2019 – Paris, France
Eigenkapital Forum: November 26 & 27, 2019 – Frankfurt, Germany